Medtronic PLC

Medtronic PLC

HQ Country
United States
Profile
About Medtronic Diabetes:
Medtronic is working together with the global community to change the way people manage diabetes. The company aims to transform diabetes care by expanding access, integrating care and improving outcomes, so people living with diabetes can enjoy greater freedom and better health.
 
About Medtronic:
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 86,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
Filtered by:
Medtronic PLC
Company
Topic
Show
 
2026
23 Jul 2026

Diabetes Management Technologies 2027-2037: Markets, Players, and Forecasts

IDTechEx Report: Dr Emma Harrop
16 Jun 2026

MedScan3D

MedScan3D is a medtech company specializing in the production of patient-specific anatomical models. The models are typically replicas of organs and body parts used to support surgical training and medical research. The company is based in the UK. IDTechEx spoke to MedScan3D at Med-Tech Expo 2026.
31 May 2026

Beta Bionics

31 May 2026

Insulet

31 May 2026

Tandem Diabetes

28 May 2026

MiniMed

MiniMed is an independent, newly public medical technology company that leverages advanced, AI-driven closed-loop systems and a high-margin recurring consumable model to automate global diabetes management.
Included are:
28 May 2026

Dexcom

Dexcom is a US-based biotech company, founded in 1999. The company is one of the market leaders in the continuous glucose monitoring (CGM) industry.
17 May 2026

Abbott Diabetes Care

Abbott Diabetes Care is a division of American multinational company Abbott Laboratories. Today, Abbott Diabetes Care is a major player in the continuous glucose monitoring market — the company's "Freestyle" brand of continuous glucose monitors (CGMs) is believed to be the most widely used CGM device.
8 May 2026

Materials for Bone Implants 2026-2036: Trends, Players, and Forecasts

IDTechEx Report: Dr Felix Wei
2025
22 Jan 2025

Development of Closed-Loop Insulin Systems

Innovation map for development of closed-loop insulin systems.
20 Jan 2025

Insulin Delivery

Innovation map for insulin delivery.
20 Jan 2025

Continuous Glucose Monitoring

Innovation map of continuous glucose monitoring.
2024
20 Nov 2024

Wearable Sensors Market 2025-2035: Technologies, Trends, Players, Forecasts

IDTechEx Report:
28 Oct 2024

Senseonics

Senseonics is a medical technology company specializing in long-term, implantable continuous glucose monitoring (CGM) systems under the Eversense brand.
31 Jul 2024

Brain Computer Interfaces 2025-2045: Technologies, Players, Forecasts

IDTechEx Report:
3 Jul 2024

Flexible Batteries Market 2025-2035: Technologies, Forecasts, and Players

IDTechEx Report: Daniel Parr and Dr Xiaoxi He
19 Jan 2024

Digital Health and Artificial Intelligence 2024-2034: Trends, Opportunities, and Outlook

IDTechEx Report:
2023
17 Jul 2023

Flexible Hybrid Electronics 2024-2034

IDTechEx Report:
20 Mar 2023

Inreda Diabetic

Inreda Diabetic is a Dutch medical device company, founded by mechanical engineer Robin Koops in 2004 with headquarters in Goor. The company is developing the Inreda Artificial Pancreas (or the Inreda AP) for automatic glucose regulation for diabetes management.
20 Mar 2023

Wearable Technology Forecasts 2023-2033

IDTechEx Report: